WeRide Inc. — Capital/Financing Update 2013

Apr 19, 2013

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [104 x 62] intentionally omitted <==

UNITED GENE HIGH-TECH GROUP LIMITED 聯合基因科技集團有限公司

(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)

(Stock Code: 399)

SUPPLEMENTAL AGREEMENTS IN RELATION TO THE EXTENSION OF LONG STOP DATE OF THE PLACING AGREEMENT AND THE SUBSCRIPTION AGREEMENT

Reference is made to the announcement of United Gene High-Tech Group Limited (the “ Company ”) dated 18 February 2013 (the “ Announcement ”) in relation to, among others, (i) the placing of Convertible Bonds A of up to an aggregate principal amount of HK$74,000,000 under the Specific Mandate; and (ii) the subscription of Convertible Bonds B in an aggregate principal amount of HK$59,000,000 under the Specific Mandate. Unless the context otherwise requires, capitalized terms used in this announcement shall have the same meaning as those defined in the Announcement.

1. THE SUPPLEMENTAL AGREEMENT TO THE PLACING AGREEMENT

On 19 April 2013, the Company and the Placing Agent entered into the supplemental agreement to the Placing Agreement to extend the long stop date for fulfillment of the conditions precedent to 30 June 2013 (or such later time and date as the Placing Agent and the Company shall agree in writing).

Save and except the aforesaid extension, all other terms and conditions of the Placing Agreement remain unchanged.

1

2. THE SUPPLEMENTAL AGREEMENT TO THE SUBSCRIPTION AGREEMENT

On 19 April 2013, the Company and the Subscribers entered into the supplemental agreement to the Subscription Agreement to extend the long stop date for fulfillment of the conditions precedent to 30 June 2013 (or such later time and date as the Subscribers and the Company shall agree in writing).

Save and except the aforesaid extension, all other terms and conditions of the Subscription Agreement remain unchanged.

By Order of the Board United Gene High-Tech Group Limited Lee Nga Yan Executive Director

Hong Kong, 19 April 2013

As at the date of this announcement, the Board comprises Ms. Jiang Nian (chairman & non-executive Director), Ms. Lee Nga Yan (executive Director), Dr. Guo Yi (executive Director), Ms. Xiao Yan (non-executive Director), Ms. Wu Yanmin (non-executive Director), Ms. Chen Weijun (independent non-executive Director), Dr. Zhang Zhihong (independent non-executive Director) and Mr. Wang Rongliang (independent non-executive Director).

2